Literature DB >> 1685082

Structural characterization of human alveolar bone proteoglycans.

R J Waddington1, G Embery.   

Abstract

Proteoglycans were extracted from EDTA-demineralized human alveolar bone under dissociative conditions using 4 M guanidinium chloride in the presence of protease inhibitors. The extract was further purified by anion-exchange chromatography on DEAE-Sephacel, using a step-wise salt gradient. The proteoglycan-rich fraction was analysed for carbohydrate, protein and amino acid composition and molecular size by SDS-PAGE. Glycosaminoglycan content was determined by cellulose acetate electrophoresis after proteolysis. The sulphate isomers of the glycosaminoglycans were confirmed by Fourier-transformed infra-red spectroscopy. Two chondroitin sulphate-proteoglycan species were identified with molecular weights of 79 and 55-65 kDa, respectively. The core proteins had molecular weights of 49 kDa for both proteoglycans, with the amino acid content rich in glycine, leucine, glutamate and aspartate. The chondroitin sulphate chains were mainly as the 4-sulphate isomer forms although low but detectable amounts of 6-sulphate isomer were also present.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685082     DOI: 10.1016/0003-9969(91)90115-b

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  3 in total

1.  The influence of fluoride on proteoglycan structure using a rat odontoblast in vitro system.

Authors:  R J Waddington; G Embery; R C Hall
Journal:  Calcif Tissue Int       Date:  1993-05       Impact factor: 4.333

2.  Lipopolysaccharide alters decorin and biglycan synthesis in rat alveolar bone osteoblasts: consequences for bone repair during periodontal disease.

Authors:  Helen C Roberts; Ryan Moseley; Alastair J Sloan; Sarah J Youde; Rachel J Waddington
Journal:  Eur J Oral Sci       Date:  2008-06       Impact factor: 2.612

Review 3.  X-linked diseases: susceptible females.

Authors:  Barbara R Migeon
Journal:  Genet Med       Date:  2020-04-14       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.